Pharmacopsychiatry 2011; 44(2): 67-71
DOI: 10.1055/s-0030-1268427
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Changes in Gustatory Perceptions of Patients with Major Depression Treated with Vagus Nerve Stimulation (VNS)

W. Sperling1 , 4 , T. Biermann1 , 4 , R. Spannenberger1 , M. Clepce1 , F. Padberg2 , U. Reulbach3 , J. Kornhuber1 , N. Thuerauf1
  • 1Department of Psychiatry and Psychotherapy, University Hospital of Erlangen, Erlangen, Germany
  • 2Department of Psychiatry and Psychotherapy, Ludwig Maximilians Universität Munich, Munich, Germany
  • 3Department of Public Health and Primary Care, Trinity College Centre for Health Sciences, Dublin, Ireland
  • 4These authors contributed equally to this work
Further Information

Publication History

received 26.07.2010 revised 06.10.2010

accepted 19.10.2010

Publication Date:
14 December 2010 (online)

Abstract

Background: Olfactory and gustatory functions were investigated before and during vagus nerve stimulation (VNS) in a group of 9 patients with therapy-resistant depression, implanted with a VNS system.

Methods: Gustation and olfaction were tested using standard sniffing tests. Subjects participated in 2 sessions with the vagal stimulator switched on and off, respectively.

Results: Under conditions of stimulation of the VNS, there were statistically significant differences of the threshold of perception, with an intensification of the taste “sweet” (Z=−2.0; p=0.048) and “bitter” (Z=−2.5; p=0.011) compared to the “off-mode”. A statistical trend (Z=−1.7; p=0.098) for increased intensity of the taste “salty” was observed, however, these results would supposedly disappear after correction for multiple testing presumably due to the large number of variables and the small sample size. There were no statistically relevant differences concerning olfactory perception.

Conclusions: The changes of gustatory perception under conditions of vagal nerve stimulation observed in this study show another important central nervous effect of vagal stimulation on the limbic system that might be of importance in the elucidation of mechanisms of action of VNS especially on refractory depression.

References

  • 1 Kennedy SH, Giacobbe P. Treatment resistant depression – advances in somatic therapies.  Ann Clin Psychiatry. 2007;  19 279-287
  • 2 Beekwilder JP, Beems T. Overview of the clinical applications of vagus nerve stimulation.  J Clin Neurophysiol. 2010;  27 130-138
  • 3 Groves DA, Brown VJ. Vagal nerve stimulation: a review of its applications and potential mechanisms that mediate its clinical effects.  Neurosci Biobehav Rev. 2005;  29 493-500
  • 4 Bajbouj M, Merkl A, Schlaepfer TE. et al . Two-year outcome of vagus nerve stimulation in treatment-resistant depression.  J Clin Psychopharmacol. 2010;  30 273-281
  • 5 Sperling W, Kornhuber J, Wiltfang J. et al . Combined VNS-rTMS treatment in a patient with therapy resistant depression.  Pharmacopsychiatry. 2007;  40 39-40
  • 6 Sperling W, Reulbach U, Maihofner C. et al . Vagus nerve stimulation in a patient with Gilles de la Tourette syndrome and major depression.  Pharmacopsychiatry. 2008;  41 117-118
  • 7 Manta S, Dong J, Debonnel G. et al . Enhancement of the function of rat serotonin and norepinephrine neurons by sustained vagus nerve stimulation.  J Psychiatry Neurosci. 2009;  34 272-280
  • 8 Sperling W, Reulbach U, Bleich S. et al . Cardiac effects of vagus nerve stimulation in patients with major depression.  Pharmacopsychiatry. 2010;  43 7-11
  • 9 Henry TR. Therapeutic mechanisms of vagus nerve stimulation.  Neurology. 2002;  59 S3-14
  • 10 Nemeroff CB, Mayberg HS, Krahl SE. et al . VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms.  Neuropsychopharmacology. 2006;  31 1345-1355
  • 11 Wang H, Chen X, Lin Z. et al . Long-term effect of vagus nerve stimulation on interictal epileptiform discharges in refractory epilepsy.  J Neurol Sci. 2009;  284 96-102
  • 12 Vonck K, De Herdt V, Boon P. Vagal nerve stimulation – a 15-year survey of an established treatment modality in epilepsy surgery.  Adv Tech Stand Neurosurg. 2009;  34 111-146
  • 13 Boon P, Raedt R, de Herdt V. et al . Electrical stimulation for the treatment of epilepsy.  Neurotherapeutics. 2009;  6 218-227
  • 14 Lomarev M, Denslow S, Nahas Z. et al . Vagus nerve stimulation (VNS) synchronized BOLD fMRI suggests that VNS in depressed adults has frequency/dose dependent effects.  J Psychiatr Res. 2002;  36 219-227
  • 15 Henry TR, Bakay RA, Pennell PB. et al . Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation.  Epilepsia. 2004;  45 1064-1070
  • 16 Pardo JV, Sheikh SA, Schwindt GC. et al . Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.  Neuroimage. 2008;  42 879-889
  • 17 Primeaux SD, Barnes MJ, Bray GA. Olfactory bulbectomy increases food intake and hypothalamic neuropeptide Y in obesity-prone but not obesity-resistant rats.  Behav Brain Res. 2007;  180 190-196
  • 18 Garcia-Diaz DE, Aguilar-Baturoni HU, Guevara-Aguilar R. et al . Vagus nerve stimulation modifies the electrical activity of the olfactory bulb.  Brain Res Bull. 1984;  12 529-537
  • 19 Ruggiero DA, Anwar S, Kim J. et al . Visceral afferent pathways to the thalamus and olfactory tubercle: behavioral implications.  Brain Res. 1998;  799 159-171
  • 20 Saper CB, Loewy AD. Efferent connections of the parabrachial nucleus in the rat.  Brain Res. 1980;  197 291-317
  • 21 Kobal G, Hummel T, Sekinger B. et al . “Sniffin’ sticks”: screening of olfactory performance.  Rhinology. 1996;  34 222-226
  • 22 Weiffenbach JM. Taste-quality recognition and forced-choice response.  Percept Psychophys. 1983;  33 251-254
  • 23 Henkin RI. Testing taste.  Lancet. 1987;  2 515
  • 24 Landis BN, Beutner D, Frasnelli J. et al . Gustatory function in chronic inflammatory middle ear diseases.  Laryngoscope. 2005;  115 1124-1127
  • 25 Kirchner A, Landis BN, Haslbeck M. et al . Chemosensory function in patients with vagal nerve stimulators.  J Clin Neurophysiol. 2004;  21 418-425
  • 26 Kringelbach ML, Berridge KC. The functional neuroanatomy of pleasure and happiness.  Discov Med. 2010;  9 579-587
  • 27 Dichter GS, Smoski MJ, Kampov-Polevoy AB. et al . Unipolar depression does not moderate responses to the sweet taste test.  Depress Anxiety. 2010;  27 589-563
  • 28 Zunszain PA, Anacker C, Cattaneo A. et al . Glucocorticoids, cytokines and brain abnormalities in depression.  Prog Neuropsychopharmacol Biol Psychiatry. 2010 Apr 18;  [Epub ahead of print]
  • 29 Pagani M, Salmaso D, Nardo D. et al . Imaging the neurobiological substrate of atypical depression by SPECT.  Eur J Nucl Med Mol Imaging. 2007;  34 110-120
  • 30 Ballmaier M, Toga AW, Blanton RE. et al . Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex.  Am J Psychiatry. 2004;  161 99-108
  • 31 Rolls ET, Baylis LL. Gustatory, olfactory, and visual convergence within the primate orbitofrontal cortex.  J Neurosci. 1994;  14 5437-5452
  • 32 Rosenbaum JF, Heninger G. Vagus nerve stimulation for treatment-resistant depression.  Biol Psychiatry. 2000;  47 273-275

Correspondence

W. SperlingMD 

Department of Psychiatry and

Psychotherapy

University Hospital of Erlangen

Schwabachanlage 6

91054 Erlangen

Germany

Phone: +49/9131/853 6194

Fax: +49/9131/853 6002

Email: Wolfgang.Sperling@uk-erlangen.de

    >